ATH 14.3% 0.3¢ alterity therapeutics limited

Ann: Prana Provides Update on Research and Develo, page-5

  1. 3,147 Posts.
    lightbulb Created with Sketch. 800
    re: Ann: Prana Provides Update on Research an... I've heard that something is rumbling..... but what exactly I don't know.

    They have been very tight lipped about PBT2 since the successful phase 2a trial results back in Feb. By now the next phase of testing should be completed, but they said very little in the AGM annoucement? Only that 'ultimately PBT2 may be used for treatment for Huntington's aswell as Alzheimers'.

    I'm hopeful they've completed another round of succesful trials and a big pharmaceutical shark is finally taking to bite.

 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(14.3%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $11.18K 3.279M

Buyers (Bids)

No. Vol. Price($)
38 52064257 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 126697935 22
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.